Yellow nail syndrome associated with thiol compound therapy for rheumatoid arthritis. Two case reports
2002; Elsevier BV; Volume: 69; Issue: 4 Linguagem: Inglês
10.1016/s1297-319x(02)00421-9
ISSN1778-7254
AutoresGaëlle Lehuédé, Éric Toussirot, J Despaux, Fabrice Michel, Daniel Wendling,
Tópico(s)Myasthenia Gravis and Thymoma
ResumoYellow nail syndrome is characterized by ungual dystrophy, lower limb lymphedema, and pleural effusions or bronchiectasis. Rheumatoid arthritis is the autoimmune disorder most often associated with yellow nail syndrome. We report two new cases of yellow nail syndrome in patients receiving thiol compound therapy for rheumatoid arthritis. Eight similar cases have been reported since 1979, suggesting a possible causative effect of this class of drugs.
Referência(s)